Published in Immunology on February 01, 1993
Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med (1995) 1.68
Stress-induced enhancement of skin immune function: A role for gamma interferon. Proc Natl Acad Sci U S A (2000) 1.39
Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. J Allergy Clin Immunol (2009) 0.96
UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology (1999) 0.95
Inducible interleukin-4-secreting cells provoked in mice during chemical sensitization. Immunology (1994) 0.87
Serum antibody responses by male and female C57Bl/6 mice infected with Giardia muris. Clin Exp Immunol (1994) 0.85
The role of interleukin-4 in ultraviolet B light-induced immunosuppression. Immunology (1997) 0.85
Impaired contact hypersensitivity to trinitrochlorobenzene in interleukin-4-deficient mice. Immunology (1999) 0.84
Limiting dilution analysis reveals the precursors of interleukin-4-producing CD4+ cells induced by protein immunization. Immunology (1994) 0.83
Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis. PLoS One (2009) 0.83
Major histocompatibility complex control of the class of the immune response to the hapten trinitrophenyl. Immunology (1995) 0.81
Decorin potentiates interferon-γ activity in a model of allergic inflammation. J Biol Chem (2013) 0.81
The kinetics of cytokine production by draining lymph node cells following primary exposure of mice to chemical allergens. Immunology (1994) 0.80
Demethylnobiletin inhibits delayed-type hypersensitivity reactions, human lymphocyte proliferation and cytokine production. Br J Pharmacol (2007) 0.78
The role of CD4 molecules in the induction phase of contact hypersensitivity cytokine profiles in the skin and lymph nodes. Immunology (1996) 0.77
Local and systemic effects of co-stimulatory blockade using cytotoxic T lymphocyte antigen-4-immunoglobulin in dinitrofluorobenzene- and oxazolone-induced contact hypersensitivity in mice. Clin Exp Immunol (2013) 0.77
Oral administration of Vaccinium uliginosum L. extract alleviates DNCB-induced atopic dermatitis in NC/Nga mice. J Med Food (2014) 0.76
Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A (1987) 14.24
Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (1987) 13.03
Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature (1985) 11.55
Generation and analysis of interleukin-4 deficient mice. Science (1991) 8.80
Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol (1990) 7.93
IL-4 directs the development of Th2-like helper effectors. J Immunol (1990) 7.20
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med (1990) 6.35
Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol (1988) 5.80
Cloning and expression of murine immune interferon cDNA. Proc Natl Acad Sci U S A (1983) 5.25
Structure of wild-type and mutant mouse beta 2-microglobulin genes. Cell (1982) 2.97
Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev (1991) 2.85
The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J Immunol (1989) 2.40
Induction and recall in contact sensivitity. Changes in skin and draining lymph nodes of intact and thymectomized mice. J Exp Med (1969) 2.27
Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med (1991) 2.24
Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction. J Immunol (1990) 1.81
Distribution of immunogenic cells after painting with the contact sensitizers fluorescein isothiocyanate and oxazolone. Different sensitizers form immunogenic complexes with different cell populations. Immunology (1980) 1.53
Contact sensitivity to oxazolone in the mouse. VIII. Demonstration of several classes of antibody in the sera of contact sensitized and unimmunized mice by a simplified antiglobulin assay. Immunology (1972) 1.36
Differential production of IL-2 and IL-4 mRNA in vivo after primary sensitization. J Immunol (1990) 1.30
Clonal heterogeneity in colony stimulating factor production by murine T lymphocytes. J Cell Physiol (1985) 1.22
Reaginic antibody produced in mice with contact sensitivity. J Exp Med (1976) 1.15
Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to trinitrochlorobenzene. J Immunol (1992) 1.12
Sudden appearance of anti-protein IgG1-forming cell precursors early during primary immunization. Proc Natl Acad Sci U S A (1989) 1.05
Antigen-specific inhibition of IL-2 and IL-3 production in contact sensitivity to TNP. Immunology (1989) 0.96
Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against gamma-interferon. Clin Exp Immunol (1988) 0.95
In vivo effects of anticytokine antibodies on isotype restriction in Mesocestoides corti-infected BALB/c mice. Infect Immun (1991) 0.89
Tissue distribution of murine hemopoietic growth factor mRNA production. J Cell Physiol (1989) 0.89
Contact hypersensitivity. Curr Opin Immunol (1989) 0.88
Human, rat or mouse hybridomas secrete high levels of monoclonal antibodies following transplantation into mice with severe combined immunodeficiency disease (SCID). J Immunol Methods (1985) 0.82
A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity (2001) 9.45
Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J (1987) 7.45
Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor. Nature (1984) 4.46
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis (2012) 2.52
Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol (1999) 2.48
Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun (1988) 2.04
Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities. J Immunol (1982) 1.80
A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol (1996) 1.67
Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis. J Immunol (1992) 1.64
Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. Immunol Rev (1982) 1.63
Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009. Euro Surveill (2010) 1.56
Cytokine production in the murine response to brucella infection or immunization with antigenic extracts. Immunology (1993) 1.54
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clin Exp Immunol (1984) 1.51
Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect Immun (1993) 1.49
A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol (1998) 1.43
Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses. Mol Biol Med (1987) 1.42
Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill (2011) 1.40
In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol (1996) 1.39
Co-engagement of CD3 with LFA-1 or ICAM-1 adhesion molecules enhances the frequency of activation of single murine CD4+ and CD8+ T cells and induces synthesis of IL-3 and IFN-gamma but not IL-4 or IL-6. Int Immunol (1992) 1.37
A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013. Euro Surveill (2013) 1.35
Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures. J Immunol (1984) 1.33
Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts. Infect Immun (1995) 1.33
Evidence for the stochastic acquisition of cytokine profile by CD4+ T cells activated in a T helper type 2-like response in vivo. Eur J Immunol (1995) 1.24
Clonal heterogeneity in colony stimulating factor production by murine T lymphocytes. J Cell Physiol (1985) 1.22
Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones. J Immunol (1984) 1.20
Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR. Proc Natl Acad Sci U S A (1992) 1.19
Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill (2011) 1.19
IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations. Cell Immunol (1997) 1.18
Stimulator cell requirements for allospecific T cell subsets: specialized accessory cells are required to activate helper but not cytolytic T lymphocyte precursors. J Immunol (1983) 1.16
Alternative splicing generates variants in important functional domains of human slow skeletal troponin T. J Biol Chem (1987) 1.16
Independent regulation of granulocyte-macrophage colony-stimulating factor and multi-lineage colony-stimulating factor production in T lymphocyte clones. J Immunol (1986) 1.14
Cutting edge: stable epigenetic inheritance of regional IFN-gamma promoter demethylation in CD44highCD8+ T lymphocytes. J Immunol (1999) 1.13
Heterogeneity in lymphokine profiles of CD4+ and CD8+ T cells and clones activated in vivo and in vitro. Immunol Rev (1991) 1.09
Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation (2001) 1.09
Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection. Eur J Immunol (1996) 1.07
Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones. J Immunol (1984) 1.05
The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009. Euro Surveill (2010) 0.99
Soluble receptors neutralizing TNF-alpha and IL-1 block stress-triggered murine abortion. Am J Reprod Immunol (1997) 0.99
Methodological issues in volumetric magnetic resonance imaging of the brain in the Edinburgh High Risk Project. Psychiatry Res (1999) 0.98
Characteristics of colony-stimulating factor production by murine T-lymphocyte clones. Exp Hematol (1985) 0.97
Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway. Eur J Immunol (1996) 0.96
Activated T cells from draining lymph nodes and an effector site differ in their responses to TCR stimulation. J Immunol (1997) 0.96
Comparison of thymic and peripheral T cell Ly-2/3 antigens. Eur J Immunol (1984) 0.95
The activated type 1-polarized CD8(+) T cell population isolated from an effector site contains cells with flexible cytokine profiles. J Exp Med (1999) 0.95
Cytolytic T lymphocyte clones. Immunobiology (1982) 0.94
Regulation of T cell cytokine production by dendritic cells. Immunol Cell Biol (2000) 0.93
Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival. Transplant Proc (1999) 0.93
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy. Cancer Immunol Immunother (1997) 0.92
Rapid establishment of a stable IL-4/IFN-gamma production profile in the antigen-specific CD4+ T cell response to protein immunization. Int Immunol (1994) 0.92
Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes. Int Immunol (1998) 0.89
GM-CSF expression is preferential to multi-CSF (IL-3) expression in murine T lymphocyte clones. Growth Factors (1989) 0.88
Stimulator requirements for primed alloreactive T cells: macrophages and dendritic cells activate T cells across all genetic disparities. Cell Immunol (1985) 0.88
Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity. Neuroscience (1998) 0.86
High-frequency activation of single CD4+ and CD8+ T cells to proliferate and secrete cytokines using anti-receptor antibodies and IL-2(1). Int Immunol (1991) 0.84
Heterogeneity of inhibition of cytolytic T lymphocyte clones by monoclonal anti-Lyt-2/3 antibodies: parallel effects on cytolysis, proliferation and lymphokine secretion. Adv Exp Med Biol (1982) 0.84
The CD4+ T-cell response to protein immunization is independent of accompanying IFN-gamma-producing CD8+ T cells. Immunology (1998) 0.83
Dissociated expression of granulocyte-macrophage CSF and IL-3 in short-term T cell clones from normal mice. J Immunol (1995) 0.83
Limiting dilution analysis reveals the precursors of interleukin-4-producing CD4+ cells induced by protein immunization. Immunology (1994) 0.83
Sequences from sea urchin TU transposons are conserved among multiple eucaryotic species, including humans. Mol Cell Biol (1986) 0.82
Resistance of BALB/c mice to Leishmania major infection is associated with a decrease in the precursor frequency of antigen-specific CD4+ cells secreting interleukin-4. Int Immunol (1993) 0.82
Interleukin 2 inhibitor in synovial fluid. Clin Exp Immunol (1988) 0.81
Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model. Cancer Res (1998) 0.81
Cytolytic T lymphocyte responses to metabolically inactivated stimulator cells. II. Effect of a soluble "costimulator" factor(s) in primary and secondary mixed leukocyte culture. Cell Immunol (1982) 0.81
Lymphokine synthesis in vivo in an acute murine graft-versus-host reaction: mRNA and protein measurements in vivo and in vitro reveal marked differences between actual and potential lymphokine production levels. Int Immunol (1993) 0.81
Helper T cell subsets: heterogeneity, functions and development. Vet Immunol Immunopathol (1998) 0.81
Quantitative analysis of lymphokine expression in vivo and in vitro. Immunol Cell Biol (1992) 0.80
The myelopoietic inducing potential of mouse thymic stromal cells. Cell Immunol (1989) 0.79
Immunity to avian influenza A viruses. Rev Sci Tech (2009) 0.79
Lymphokine production in vivo in a murine graft-versus-host reaction. Transplant Proc (1992) 0.78
Persistence of donor-reactive CD4+ T cells in liver and spleen of rats tolerant to a liver allograft. Transplantation (1998) 0.78
Survival of the myeloid progenitor cell line FDC-P1 is prolonged by interferon-gamma or interleukin-4. Growth Factors (1992) 0.78
Identification of the 70kD heat shock cognate protein (Hsc70) and alpha-actinin-1 as novel phosphotyrosine-containing proteins in T lymphocytes. Biochem Biophys Res Commun (1996) 0.78
Cytolytic T lymphocyte responses to metabolically inactivated stimulator cell. I. Metabolic inactivation impairs both CD and LD antigen signals. Cell Immunol (1982) 0.78
Nature versus nurture in T cell cytokine production. J Leukoc Biol (1999) 0.77
Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes. Immunology (2000) 0.77
The labyrinthine ways of cancer immunotherapy--T cell, tumor cell encounter: "how do I lose thee? Let me count the ways". Adv Cancer Res (1998) 0.77
Murine cytolytic CD8+ T cell clones generated in a high cloning efficiency, accessory cell-free culture system express a restricted lymphokine profile. Cell Immunol (1992) 0.77
Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer. Cancer Res (1998) 0.77
Synthesis and analysis of peptide to murine CD4 molecules. Transplant Proc (1989) 0.76
Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors. J Exp Med (1990) 0.75
Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation. Immunology (1996) 0.75
Production of macrophage activating factor by cytolytic and noncytolytic T lymphocyte clones. Adv Exp Med Biol (1982) 0.75
Activation of lymphokine mRNA and protein synthesis in vivo in a murine graft-vs-host reaction. Transplant Proc (1993) 0.75
Absorption of normal lymphocytes on allogeneic spleen monolayers: depletion of alloreactivity is due to inhibition of CTL induction by released monolayer cells. J Immunol (1981) 0.75
Independent regulation of cytokine genes in T cells: the paradox in the paradigm. Transplantation (1998) 0.75
CD4 ligation promotes the IL-4-independent development of IL-4-producing clones from naive CD4(+) T cells. J Immunol (2001) 0.75
The antigen-specific signal in T-lymphocyte activation by alloantigen. Nouv Rev Fr Hematol (1979) 0.75
Cloning and expression of the gene for murine granulocyte-macrophage colony-stimulating factor. Haematol Blood Transfus (1985) 0.75